MedPath

The rationale of study is that which one among Nalbuphine and Buprenorphine,is a better adjuvant yet to be explored as only few studies happened in past on this

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/03/050389
Lead Sponsor
ROHILKHAND MEDICAL COLLEGE AND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

American society of Anesthesiologists (ASA) grade 1 or 2

Posted for surgeries of lower abdomen or lower limb of different surgical specialities

Exclusion Criteria

Patient refusal for procedure

Any Neuropathy,Cardiac disease,diabetes,Nephropathy,Coagulopathy

Any known allergy to local anaesthetic

Patients with contraindications for spinal anaesthesia such as derranged coagulation profile ,raised ICP,local infection at site of needle insertion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Onset of sensory and motor block <br/ ><br>Duration of sensory and motor block <br/ ><br>Duration of postoperative analgesia <br/ ><br> <br/ ><br>Timepoint: At 2,4,6,8,10,12,14,16,18,20,30,40,50,60,90,120,180,240,360,720 minutes after block , heart rate ,ECG lead 2 ,systolic , diastolic and mean blood pressure and oxygen saturation will be recorded <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Hemodynamic responses to the drug during and after surgery <br/ ><br>Any complication or side effectsTimepoint: At 2,4,6,8,10,12,14,16,18,20,30,40,50,60.90,120,180,240,360,480,720 minutes after the block , heart rate ,ECG lead 2,systolic,diastolic and mean blood pressure and oxygen saturation will be recorded
© Copyright 2025. All Rights Reserved by MedPath